idarubicin has been researched along with Heart Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, MH; Li, DK; Yang, SC | 1 |
| Russell, R; Volkova, M | 1 |
| Barron, JT; Ghalie, R; Kaizer, H; Kakavas, PW; Parrillo, JE | 1 |
| Anderlini, P; Andreeff, M; Benjamin, RS; Ewer, MS; Kantarjian, HM; Kornblau, SM; Mackay, B; O'Brien, S; Pierce, SA; Wong, FC | 1 |
1 review(s) available for idarubicin and Heart Failure
| Article | Year |
|---|---|
Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment.
Topics: Anthracyclines; Antineoplastic Agents; Cardiotoxins; Doxorubicin; Heart Failure; Humans; Idarubicin; Prevalence; Risk Factors; Ventricular Dysfunction, Left | 2011 |
3 other study(ies) available for idarubicin and Heart Failure
| Article | Year |
|---|---|
The development of congestive heart failure and ventricular tachycardia after first exposure to idarubicin in a patient with acute myeloid leukaemia.
Topics: Adult; Antibiotics, Antineoplastic; Female; Heart Failure; Humans; Idarubicin; Leukemia, Myeloid, Acute; Tachycardia, Ventricular | 2010 |
Angiotensin converting enzyme inhibitors in bone marrow transplant recipients with depressed left ventricular function.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Echocardiography, Doppler, Color; Enalapril; Female; Gated Blood-Pool Imaging; Heart Failure; Humans; Idarubicin; Leukemia; Male; Middle Aged; Radiation Injuries; Radiotherapy; Ventricular Dysfunction, Left; Ventricular Function, Left | 1995 |
Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Female; Heart; Heart Failure; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Retrospective Studies; Risk Factors; Stroke Volume | 1995 |